# AMINOCAPROIC ACID
> **ANDA213216** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2025-05-19
## Drug
- **FDA Application Number:** ANDA213216
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMINOCAPROIC ACID
- **Generic name:** AMINOCAPROIC ACID
- **Active ingredients:** AMINOCAPROIC ACID
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Apozeal Pharmaceuticals Inc.
- **First approval:** 2025-05-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213216)
---
*AI Analytics · CC0 1.0*